眼伤宁口服液联合羊膜移植治疗角膜病变的疗效观察  

An observation of effect of yanshangning(眼伤宁)oral liquid combined with amnion transplant in treatment of corneal disease

作　　者：李翔[1] 周善璧[2] 陈斌[3] 周春阳[1] 

机构地区：[1]成都中医药大学附属医院眼科,成都61007 [2]重庆医科大学第一附属医院 [3]四川省人民医院

出　　处：《中国中医眼科杂志》2006年第1期24-26,共3页China Journal of Chinese Ophthalmology

摘　　要：目的观察中药眼伤宁口服液联合羊膜移植对角膜病变的疗效。方法对照组患者15例15只眼羊膜移植及术后用典必舒点眼,每日6次,每次1滴。观察组患者15例15只眼在对照组方法基础上加服眼伤宁口服液,每次2支,每日3次。观察比较两组患眼的羊膜成活率、治疗前后的视力和角膜透明性。结果观察组的羊膜成活率为100%,对照组的羊膜成活率为80%,两组比较差异无显著性(P>0·05);观察组治疗前后视力改善和角膜透明性明显优于对照组(P<0·01或P<0·05)。结论眼伤宁口服液可用于角膜病变羊膜移植术后的配合治疗。OBJECTIVE To observe the curative effect of Chinese medicine yanshangning （眼伤宁） oral liquid in treatment of corneal disease combined with amnion transplant. METHODS Thirty patients （30 eyes） with corneal disease were divided randomly into control group and observed group. The patients were treated with amnion transplant and Tobradex （one drop, six times day） in the control group, and treated with amnion transplant, Tobradex （one drop, six times a day） and yanshangning oral liquid （two doses, three times a day） in the observed group. The rate of surviving amnion, the vision, corneal transparence were compared between two groups. RESULTS The rate of surviving amnion is 100% in observed group, and 80% in control group. There was not no obvious difference between two group （ P 〉 0.05） . The improvement of vision and corneal transparence were better in observed group than those in control group （ P 〈 0.01 or P 〈 0.05） . CONCLUSIONS Yanshangning oral liquid can be used for match treatment after amnion transplant.

关 键 词：眼伤宁口服液 羊膜 角膜病变 

分 类 号：R772.2[医药卫生—眼科]